Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Sets Aside $2M in RFAs for Eukaryotic Genome Research

NEW YORK (GenomeWeb News) - The National Human Genome Research Institute has set aside approximately $2 million in fiscal year 2007 under two requests for applications to develop new technologies to determine functional elements in eukaryotic genomes.
 
The reissue splits the original RFA, released Jan. 6, 2004, into two separate RFAs: one for the R21 grant mechanism and the other for the R01 grant mechanism.
 
NHGRI said it would fund six to 10 new and/or competing continuation grants “to develop new and improved technologies for the efficient, comprehensive and high-throughput identification and validation of all types of sequence-based functional elements in eukaryotic genomes.”
 
The development effort is part of the Encyclopedia of DNA Elements Project, which attempts to identify all of the functional elements in the human genome.
 
The NIH agency will support “the development of novel technologies and expand the available toolbox of methods that will comprehensively identify sequence-based functional elements in eukaryotic genomes in a high-throughput manner,” the RFA said.
 
The RFAs cover:
  • Transcribed sequences, with the emphasis on non-protein-coding transcribed sequences;
  • Conserved non-coding sequences that represent functional elements;
  • Cis-acting elements that regulate gene expression at either the transcriptional or post-transcriptional levels;
  • Sequence features that affect or control various aspects of chromosome biology, including chromatin structure;
  • Epigenetic changes, such as DNA methylation and chromatin modifications; and
  • Functional elements in repetitive sequences.
Applicants may request a project period of up to three years and a budget for direct costs up to $350,000 per year, NHGRI said.

Letters of intent should be received by Oct. 30 and applications should be received by Nov. 28, according to NHGRI. Earliest anticipated start date is June 1, 2007. 

Additional information for the R21 grant mechanism can be found here.

Additional information for the R01 grant mechanism can be found here.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.